共 50 条
- [35] PRE-CLINICAL PHARMACOLOGY OF N-(PHOSPHONACETYL)-L-ASPARTATE IN DOGS, MONKEYS, AND RATS PHARMACOLOGIST, 1978, 20 (03): : 191 - 191
- [37] ROLE OF ENDOCYTOSIS AND LYSOSOMAL PH IN UPTAKE OF N-(PHOSPHONACETYL)-L-ASPARTATE (PALA) AND ITS INHIBITION OF PYRIMIDINE SYNTHESIS MEDICAL AND PEDIATRIC ONCOLOGY, 1984, 12 (01): : 80 - 80
- [38] BIOCHEMICAL PARAMETERS OF SENSITIVITY OR RESISTANCE TO N-(PHOSPHONACETYL)-L-ASPARTATE (PALA) IN MURINE NEOPLASMS PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 101 - 101
- [40] EFFECT OF URIDINE (URD) ON CLINICAL TOXICITIES DURING N-(PHOSPHONACETYL)-L-ASPARTATE (PALA) TREATMENT PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 348 - 348